These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7392516)

  • 21. Use of ethyl apovincaminate in ophthalmological therapy.
    Kahán A; Oláh M
    Arzneimittelforschung; 1976; 26(10a):1969-72. PubMed ID: 1037225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Structure of vascular walls of human retina and choroid (author's transl)].
    Yoshimoto H; Matsuyama S
    Nippon Ganka Gakkai Zasshi; 1982; 86(1):47-63. PubMed ID: 7080973
    [No Abstract]   [Full Text] [Related]  

  • 23. [Histopatological studies on vascular changes, especially on involvements in the choroidal vessels, in hypertensive retinopathy (author's transl)].
    Uyama M
    Nippon Ganka Gakkai Zasshi; 1975 Apr; 79(4):357-70. PubMed ID: 1170739
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prostaglandin R and retinal vessels (author's transl)].
    Bryk E
    Klin Oczna; 1979 Apr; 81(4):267-9. PubMed ID: 439747
    [No Abstract]   [Full Text] [Related]  

  • 25. Cavinton in the treatment of acute stroke.
    Kovács L
    Ther Hung; 1985; 33(1):50-7. PubMed ID: 3841999
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cavinton prevention of neurosensory hypoacousis in patients with different forms of tuberculosis].
    Maliavina US; Ovchinnikov IuM; Fasenko VP; Maliev BM; Kalinina MV; Dadasheva BB
    Vestn Otorinolaringol; 2003; (3):35-40. PubMed ID: 12847806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Action of Cavinton on hearing defects of different origin.
    Jasper A
    Ther Hung; 1978; 26(4):181-4. PubMed ID: 751275
    [No Abstract]   [Full Text] [Related]  

  • 28. [Role of psychophysiologic characteristics of patients in the efficacy of treatment with cavinton].
    Lil'in ET; Mar'in MI; Trubnikov VI; Vavilova TA
    Sov Med; 1983; (10):111-3. PubMed ID: 6658534
    [No Abstract]   [Full Text] [Related]  

  • 29. [Delayed-action pervincamine forte in circulatory disorders of the posterior segment of the eye].
    Bregeat P; Ryzman P
    Rev Otoneuroophtalmol; 1975; 47(5):353-8. PubMed ID: 1215739
    [No Abstract]   [Full Text] [Related]  

  • 30. [About cavinton therapy of the patients with brain vascular diseases].
    Nikitina VV; Pravdina AN; Zapatrina OV
    Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of Cavinton on the pathological changes in ischemic brain changes starting as an acute disease].
    Bałuka-Horecka M
    Przegl Lek; 1982; 39(4):325-8. PubMed ID: 7100509
    [No Abstract]   [Full Text] [Related]  

  • 32. [Vascular pattern in the extreme peripheral retina (author's transl)].
    Miyakubo H; Numaga T
    Nippon Ganka Gakkai Zasshi; 1980 Oct; 84(10):1765-76. PubMed ID: 7257994
    [No Abstract]   [Full Text] [Related]  

  • 33. [Report on the use of piribedil in vascular and hemorrhagic disease of the posterior pole of the eyeball].
    De Molfetta V; Lauri G
    Minerva Med; 1976 May; 67(26):1696-7. PubMed ID: 934522
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in lipoproteins in response to Cavinton administration in aged hyperlipaemic patients.
    Banga I; Gergely I
    Ther Hung; 1982; 30(1):25-9. PubMed ID: 6926906
    [No Abstract]   [Full Text] [Related]  

  • 35. Observations with cavinton treatment in acute cerebral ischaemic conditions.
    Kovács G
    Ther Hung; 1984; 32(4):155-7. PubMed ID: 6571201
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cavinton in the therapy of cerebrovascular disorders].
    Kalvach P; Bauer J; Ságová V
    Cesk Neurol Neurochir; 1982 Nov; 45(6):380-5. PubMed ID: 7151202
    [No Abstract]   [Full Text] [Related]  

  • 37. [Report of a trial with Pervincamine Forte Retard in 50 cases of various otological disorders].
    Oudot J
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1978 May; 27(5):361-5. PubMed ID: 149837
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical and electroencephalographic results of a double-blind test with vincamine (Pervincamine) in advanced cerebral sclerosis (author's transl)].
    Mikus P; Polák O; Ochsenreither AM
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):39-49. PubMed ID: 4602891
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pathology of choroidal circulatory disturbance. Part 4. Chorioretinopathy in choroidal circulatory disorders, clinical study (author's transl)].
    Uyama M; Koshibu A; Itotagawa S; Ohkuma H; Uraguchi K; Miki K
    Nippon Ganka Gakkai Zasshi; 1980 Nov; 84(11):1947-56. PubMed ID: 7246354
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical and Neuropsychological changes associated with vincamin treatment in cerebrovascular disease (author's transl)].
    Ambrozi L; Bruck J; Tschabitscher H
    Nervenarzt; 1982 Mar; 53(3):141-3. PubMed ID: 7078689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.